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PURPOSE: To compare the evolution of standard base excess and serum lactate level between surviving and non surviving
patients with severe sepsis and septic shock resuscitated with early goal-directed therapy.
METHODS: This is a retrospective study in an intensive care unit of a university tertiary hospital where 65 consecutive severe
sepsis and septic shock patients were observed without any intervention in the treatment by the authors of this report.
RESULTS: In our study, the mortality of severe sepsis and septic shock patients was 38%. The central venous oxygen saturation
of both groups was above 70% after the resuscitative period, excluding the second day of the non survivors group (69.8%). After
the second day, the central venous oxygen saturation was significantly higher in the survivors group (P < .001). Standard base
excess was initially low in both groups, but from the second day on, the correction of standard base excess was significantly more
successful and linear in the survivor group (P < .001). Lactate levels were similar during the evolution of both groups.
CONCLUSIONS: Although evolutive standard base excess and serum lactate level are still outcome markers in severe sepsis and
septic shock patients resuscitated with early goal-directed therapy, other studies must be performed to clarify if hemodynamic
interventions based on standard base excess and serum lactate level could be reliable to improve clinical outcomes in severe sepsis
and septic shock patients
KEYWORDS: Severe sepsis. Septic shock. Monitorization. Lactate. Metabolic acidosis.
INTRODUCTION
Severe sepsis and septic shock are the major causes of
admission and death in intensive care units (ICUs). This
fact has motivated clinical trials aiming the improvement
of care for critically ill septic patients.1 As a result, low
dosages of corticosteroids,2 strict glycemic control,3
recombinant human activated protein C,4 protective
ventilatory strategies5,6 and early goal-directed hemody-
namic therapy7 have been associated with improved out-
comes. The latter trial found that early aggressive manage-
ment of hemodynamics targeting a balance of oxygen con-
sumption and delivery is an effective treatment of severe
sepsis and septic shock patients.7 This finding contrasted
with other clinical studies in which hemodynamic optimi-
zation was not clearly effective.8,9 In early goal-directed
therapy, the precocious match between oxygen consump-
tion and delivery is achieved with central venous oxygen
saturation (ScvO2) ≥ 70%. This approach has been respon-
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sible for significant reductions in in-hospital mortality.7 As
regards the metabolic consequences of shock and
hemodynamic management, there are other simple moni-
toring tools such as serum lactate levels and standard base
excess (SBE) that can be used in critical illness.10-13 When
measured at admission and within the first days of ICU stay,
these variables are important outcome markers in conven-
tionally resuscitated patients.10 However, to the best of our
knowledge, there are few clinical studies testing interven-
tions based on serum lactate level or SBE, and there are no
studies showing evolutive serum lactate level and SBE as
outcome markers following early goal-directed therapy.14-15
The aim of this study was to compare ScvO2, serum lactate
levels, and SBE evolution between surviving and non sur-
viving patients with severe sepsis and septic shock who un-
derwent early goal-directed hemodynamic therapy.
METHODS
Data were retrieved from our prospectively collected
database for a tertiary teaching 7-bed ICU hospital in São
Paulo, Brazil. The period investigated was July 2003 to
May 2004. The following data were collected: age, gen-
der, APACHE II score, length of stay in the ICU, clinical
outcome, need for mechanical ventilation, diagnosis of
acute respiratory distress syndrome (ARDS),16 need for di-
alysis, and infection source. These sets of data were col-
lected from the patients as they were admitted with diag-
nosis of severe sepsis and septic shock according to the con-
sensus conference criteria.17
Blood samples were obtained as required; at admission
all patients were monitored with an arterial and central ve-
nous line; after this initial period every procedure, such as
fluid challenges, inotropic agents, and vasopressors, was
checked with a new blood samples 10 to 15 minutes after
stabilization, as is the standard of care of our unit. The
number of patient blood samples was variable as required
for additional interventions. After reaching a ScvO2 e•70%,
(or in the absence of such response, but with a higher
reached ScvO2), new blood samples were collected every
6 hours during the first 24 hours. Data compatible with a
fully resuscitated patient retrieved from the database were
the establishment of a plateau, that is, a steady level with-
out great variations above or under the current value.
ScvO2 was obtained through the gas analysis of blood
drawn from the central venous catheter. The plateau value
of ScvO2 was taken to be that collected after the initial re-
suscitation of patients as the optimized compatible; after-
wards, a mean daily value was determined until the fifth
day. The SBE and serum lactate levels were obtained
through the arterial blood analysis gained from the arte-
rial line at the same time of central venous blood sample
collection as described above. Central venous catheter po-
sition was previously verified, and possible complications
were ruled out with a chest X ray. All blood samples were
analyzed in an AVL Omni Roche gas analyzer (Basel, Swit-
zerland), and to determine the SBE value, the Van Slyke
method was used.18
The ScvO2, serum lactate level, and SBE were com-
pared between the survivor and non survivor groups dur-
ing the first 5 days of evolution. Data are shown as medi-
ans and interquartile range. Single medians between groups
were compared using the Mann Whitney U test, and cat-
egorical data were compared using Fisher or chi-square
analysis as indicated. To show and analyze the evolution
during the first 5 days, data were considered normal using
the Kolmogorov-Smirnov model, and then shown as mean
± standard deviation and tested with 2-way analysis of vari-
ance (ANOVA). The commercially available SPSS 10.0 sta-
tistical package was used, taking P < .05 as a significant
level. Bonferroni‘s correction for continuity was applied
when necessary.
RESULTS
During 10 months, 65 patients were observed, 25 with
severe sepsis and 40 with septic shock. The general char-
acteristics and infection source of the whole group (survi-
vors and non survivors) are shown in Table 1. In our study,
the mortality of severe sepsis and septic shock patients was
38%. The median of age and APACHE II score were higher
in non survivors, as were the number of patients who
needed mechanical ventilation. The infection sources were
similar between survivors and non survivors. Within the re-
suscitative period, patients received a median of 5,302
(range, 4,523–7,310) mL of crystalloids resulting in a posi-
tive fluid balance of 4,802 (range, 3,548–5,281) mL dur-
ing those twelve hours. Forty patients needed a median of
0.3 (range, 0.2–0.3) µg/kg/minute of norepinephrine as a
vasopressor, and 39 patients needed a median of 13 (range,
10–22) µg/kg/minute of dobutamine as an inotropic agent.
The mean ScvO2 after the initial resuscitation on the first
day of ICU stay (Figure 1 - Panel A) was above 70% in
both groups. After the second day, the ScvO2 of survivors
was significantly higher than that of non survivors, and ex-
cluding the second day, the median ScvO2 of both groups
was higher than 70%. The SBE was low in both groups af-
ter resuscitation; during the following days, there was a lin-
ear trend to normalization in the survivor group, with sig-
nificant differences in individual comparisons of days 3,
4, and 5 with day 1 (Figure 1 - Panel B). In the non survi-
vor group, there was a worsening of SBE on the second
49
CLINICS 2006;61(1):47-52 Evolutive standard base excess and serum lactate level
Park M et al.
day, with a subsequent slow recovery. Serum lactate levels
were similar in both groups during the first 5 days of evo-
lution excluding the second day, when the non survivor
group had a higher level of serum lactate than the survivor
group (Figure 1 - Panel C).
DISCUSSION
The first hours following the diagnosis of severe sepsis
and septic shock are known as the “golden hours”. In this
period, aggressive hemodynamic resuscitation is related to
higher survival rates and reduced organ dysfunctions.7 The
match between oxygen delivery/consumption is the ration-
ale for this phenomena.7,8,19 After the “golden hours”, the
aggressive hemodynamic resuscitation is no longer efficient
in restoring organ function or in decreasing mortality.19 It
may surmised that following this initial period, irreversible
endothelial and organ cellular dysfunctions and set in and
consequently the benefits of aggressive hemodynamic re-
suscitation are lost.19-21
The ScvO2 ≥ 70% has been considered a marker of sys-
temic oxygen delivery/consumption matching,7,8,20 but this
Table 1 - General characteristics of survivors, nonsurvivors, and the whole group
Characteristic All patients Survivors Nonsurvivors P value
(n = 65) (n = 40) (n = 25)
Age* - year 54 [33,69] 41 [27,61] 67 [51,63] <.001
Gender (Females) - no (%) 28 (43) 20 (50) 8 (32) .24
APACHE II* 24 [16,27] 21 [12,25] 26 [18,30] .03
Days in ICU* 10 [6,13] 10 [6,13] 9 [7,16] .91
ARDS - no (%) 25 (38) 16 (40) 9 (36) .95
MV** - no (%) 57 (88) 32 (80) 25 (100) .02
Dialysis - no (%) 5 (8) 2 (5) 3 (12) .37
Septic shock - no (%) 50 (77) 28 (70) 22 (88) .87
Severe sepsis - no (%) 15 (23) 12 (30) 3 (12) .13
Sepsis source
Pneumonia - no (%) 40 (62) 24 (60) 16 (64) .95
Abdominal - no (%) 10 (16) 6 (14) 4 (16) >.99
Urinary tract - no (%) 5 (8) 3 (8) 2 (8) >.99
Soft tissue - no (%) 4 (6) 2 (5) 2 (8) .64
Catheter - no (%) 3 (4) 3 (8) 0 (0) .28
Unidentified - no (%) 3 (4) 2 (5) 1 (4) >.99
* median range; ** MV denotes the number of patients on mechanical ventilation
no denotes the number of patients
Figure 1 - Panel A. Central venous saturation of survivors and non survivors, the analysis within group did not disclose differences during the evolution (P
= 0.358, ANOVA two way). (*) Between groups there were differences in days 2,3,4 and 5 (P < 0.001, ANOVA two way with Tukey post hoc analysis).
There was not factor time interaction (P = 0.964, ANOVA two way). Panel B. Standard base excess of survivors and non survivors, the analysis within group
(#) disclose differences during the evolution (P < 0.001, ANOVA two way, with Tukey post hoc analysis showing differences between the days 3,4 and 5 vs
day 1 among the survivors). (*) Between groups there was difference in day 5 (P = 0.008, ANOVA two way with Tukey post hoc analysis). There was not
factor time interaction (P = 0.290, ANOVA two way). Panel C. Serum lactate levels of survivors and non survivors, the analysis within group did not
disclose differences during the evolution (P = 0.555, ANOVA two way). (*) Between groups there was difference in day 2 (P < 0.001, ANOVA two way with
Tukey post hoc analysis). There was not factor time interaction (P = 0.430, ANOVA two way).
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cut-off value was extrapolated from normal subjects.22-23 In
our study, all patients reached a ScvO2 ≥ 70%, with survi-
vors reaching a higher ScvO2 than non-survivors. This find-
ing can be explained by the greater dysfunctions of the mi-
crocirculation,23 24 heart, 24,25 and cellular metabolism in
nonsurvivors.21 Clinically, it is hard to interpret this fact,
but it seems that patients who reach higher ScvO2 levels
are more prone to survive. Many ICUs have used the mixed
venous saturation (SvO2) ≥ 70% as a goal of resuscitation
in severe sepsis and septic shock patients.1 We and others
have found the ScvO2 values to be higher than SvO2 val-
ues in severe sepsis and septic shock patients.26,27 Taking
all these quoted studies into account, results point out to
higher values of ScvO2 as a possible better goal in severe
sepsis and septic shock resuscitation.
The SBE can reflect a great amount of disturbances sec-
ondary to sepsis and its resuscitation,18 and low values at
admission are associated with higher mortality in the
ICU.10,11 In a previous retrospective study, any improvement
of SBE in severe sepsis and septic shock patients on the
third day of ICU stay was a strong predictor of better out-
come.28 The evolutive behavior of SBE has not been clini-
cally studied following early goal-directed therapy. 10,11 In
our results, faster improvement of SBE occurred in the sur-
vivor group. Similarly, in the Rivers study,7 a faster decre-
ment of base deficit in the early goal-directed therapy group
in relation to the control group was observed, with normal
base deficit values being achieved by the third day.
High serum lactate values at admission are also asso-
ciated with worse outcomes.10 Likewise, the persistence of
high values during the ICU stay is a predictor of death and
organ failure.12, 13 In this study, we measured serum lactate
levels before and after the early goal-directed hemodynamic
therapy. Non survivors had a slightly higher value of se-
rum lactate during the first 2 days after the admission, but
we would like to stress that it was far from a clinically sig-
nificant difference. The evolutive behavior of the serum lac-
tate level of the survivors was static within the group. Our
results conflict with those of Rivers et al,7 which showed
a progressive correction of serum lactate level that was
more accentuated in the early goal-directed therapy group.
The same investigators have shown that in severe sepsis and
septic shock patients that are conventionally resuscitated,
a serum lactate clearance greater than 10% within 6 hours
of admission was associated with better outcomes.29
In conclusion, although evolutive SBE and serum lac-
tate level are still considered to be outcome markers in sep-
tic patients treated with early goal-directed hemodynamic
therapy during their ICU stay, other studies must be per-
formed to clarify if hemodynamic interventions based on
SBE and serum lactate level could be reliable to improve
clinical outcomes in severe sepsis and septic shock patients.
RESUMO
Park M, Azevedo LCP, Maciel AT, Pizzo VR, Noritomi DT,
Cruz Neto LM da. Standard base excess e o nível sérico
de lactato evolutivos nos pacientes com sepse grave e
choque séptico reanimados com o early goal directed
therapy: ainda discriminadores de mortalidade? Clinics.
2006;60(1):47-52.
OBJETIVO: Comparar a evolução do “standard base ex-
cess” e o nível de lactato sérico entre pacientes
sobreviventes e não sobreviventes com sepse grave ou
choque séptico reanimados com o “early goal directed
therapy”.
MÉTODOS: Estudo retrospectivo em uma unidade de
terapia intensiva de um hospital escola onde sessenta e
cinco pacientes com sepse grave e choque séptico foram
observados sem intervenções.
RESULTADOS: Em nosso estudo, a mortalidade na sepse
grave e choque séptico foi de 38%. A saturação venosa cen-
tral de oxigênio nos dois grupos foi maior que 70% de-
pois da reanimação, exceto no segundo dia no grupo dos
pacientes não sobreviventes (69,8%). Depois do segundo
dia, a saturação venosa central foi significantemente mai-
or no grupo dos sobreviventes (p<0.001). O “standard base
excess” foi inicialmente baixo em ambos os grupos, mas a
partir do segundo dia a recuperação do “standard base
excess” foi significantemente mais importante e linear no
grupo dos sobreviventes (p<0.001). Os níveis de lactato fo-
ram similares na evolução dos dois grupos.
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DISCUSSÃO: O “standard base excess” e o lactato são ain-
da considerados como marcadores prognósticos em paci-
entes com sepse grave ou choque séptico reanimados de
acordo com o “early goal directed therapy”. Outros estu-
dos devem ser realizados com a intenção de demonstrar se
intervenções hemodinâmicas baseadas no “standard base
excess” e nos níveis de lactato podem ser úteis em melho-
rar desfechos clínicos em pacientes com sepse grave ou
choque séptico.
UNITERMOS: Sepse grave. Choque séptico. Monitori-
zação. Lactato. Acidose metabólica.
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